BIOL

For pain control and body recovery

Safe way to help patients ease pain, accelerate recovery from trauma and improve overall health.

Order

INTENDED USE

The device is designed to modulate the patient's immune system, treat viral diseases, reduce the postoperative rehabilitation period's duration, and relieve pain.
Individual use of the device is recommended on the prescription of a doctor who determines the duration and number of sessions and monitors the course of treatment according to the patient's clinical tests.
The device is recommended for use in medical, treatment-and-prophylactic, sanatorium and outpatient institutions.
RECOMMENDED USE OF MEDICAL DEVICE as a part of complex therapy and rehabilitation after a stroke / acute disturbance of cerebral circulation;
after COVID-19;
subacute and chronic inflammation: prostatitis, benign prostatic hyperplasia, pneumonia, bronchitis, etc.;м poorly healing wounds and immune deficiency;
injuries and diseases of joints and spine of different genesis: arthritis, osteoarthritis, synovitis, epicondylitis, bursitis, back pain, sprains, bruises, myositis, tenosynovitis, etc.;
diseases of the cardiovascular system: primary and secondary hypertension, rheumatism and more;
diseases of the nervous system: splash, radicular syndrome, vibration disease, etc.;
inflammatory tissue diseases: mastitis, postoperative infiltration, strokes, etc.

Download APP
Doctor with Device
Doctor with Device

For Whom

For professional use in wide range of industries

BIOL is perfectly suited for medical institutions, hospitals, recreational/sports institutions, rehabilitation and wellness centres. Individual use of the device is recommended via a doctor’s appointment, who will advise on the number and duration of sessions

FUNCTIONAL

Reporting

Pain reduction (back, neck, rheumatic)

Reporting

Reduction of rehabilitation period after surgery

Reporting

Modulation of a patient’s immune system: restoration of the body's natural immunity.

Reporting

Reduction of spasmodic pain

Reporting

Prevention and treatment of prostate diseases.

Reporting

Personal records in DB and detailed reporting available for every patient.

Reporting

Reduction of stress and nervous tensions.

HOW IT WORKS

The device is intended to have a therapeutic impact on tissues and internal organs of the patient by producing low-intensity, high-frequency electromagnetic field in 100-1500 MHz range. This field initiates physiochemical process that stimulates blood flow and activates perfusion. Improves flow of nutrients and accelerates the healing process.

Human Body Visualization

BIOL restores damaged tissues and speeds up overall healing process. Improved transport and absorption of calcium. Has a strong impact on growth and recovery of bones, cartilage tissue, and reduces pain.

Step 2 Visualization

Before using BIOL, the following preparations should be made: a. Place BIOL on a flat surface 1-2.5 meters away from the patient. b. Switch the device “On”. Ensure that the display on the device shows status bar and “Biopromin Ltd Biol”. The “Preparation” mode turns on automatically as soon as the device starts working. c. Choose one of the following operating modes: “Therapy” or “Rehabilitation”.

Step 3 Visualization

After “Therapy” or “Rehabilitation” mode is set, choose the duration of the session.

Step 4 Visualization

After setting the session duration, the device will automatically start with previously selected mode and will automatically switch off as soon as the session is over.

Step 5 Visualization
01 02 03 04 05

User's manual

The “Operating Instructions” contains information on the purpose, the principle of operation and the possibilities of the device. Technical and operational characteristics are indicated: basic parameters and dimensions, completeness and design of the device. The order of its maintenance, transportation, storage and disposal. Service life and manufacturer’s warranty. It describes the conduct of the session, the algorithm for preparing the device for use and setting up a therapy and rehabilitation program

PARAMETERS

Scope of application +

Rehabilitation after stroke.Together with the standard treatment protocol, as an adjunct to therapy, it helps to shorten the recovery period

Injuries and diseases of joints and spine of different genesis +

Arthritis, arthrosis, parasinovitis, epicondylitis, bursitis, back pain, stretching, bruising, myositis, tenosynovitis, poorly healing wounds, etc.

Subacute and chronic inflammatory diseases +

Bronchitis, pneumonia, cholecystitis, salpingitis, prostate disease, etc.

Diseases of the cardiovascular system +

Primary and secondary hypertension, rheumatism, etc .;

Diseases of the nervous system +

Applause, radicular pain, vibrational disease, and others.

Diseases of the respiratory and hearing organs without purulent process +

Acute, subacute and chronic inflammation of the paranasal sinuses, middle ear, tonsils and oral cavity, bronchial asthma, etc

Inflammatory Skin Diseases +

Furuncles, mastitis, postoperative infiltration, bruising, etc.

More information (Download PDF)

UNIQUENESS

Non-Invasive

For private and professional use

The small size allows the device to be used conveniently in any medical facility or privately at home by a doctor’s recommendation

Chronic pain reduction without any drugs

Treatments and rehabilitation sessions can be used as a consistent reduction of chronic pain, as the device always targets the primary source

Analysis
Sustainability

Improve the quality of life for patients with cancer

BIOL is used to relieve symptoms and side effects of cancer, such as pain, nausea, fatigue and anxiety.

SOFTWARE BIOL-24

A short video tutorial on how to use the BIOL medical device management application. The application is installed and runs on all popular OS: WINDOWS, iOS, macOS, ANDROID, LINUX, and UNIX. We recommend using the following browsers to install or use the application: CHROME, EDGE, VIVALDI for WINDOWS, macOS, ANDROID, LINUX, UNIX and BLUEFLY if you use iOS. Your mobile gadget or computer must have a BLUETOOTH BLE enabled. Switch on your BIOL medical device and watch this video. Now, you can enjoy easy and convenient remote control of your medical device.

More information (Video)

OPERATING THEORY

Studies of the influence of electromagnetic fields (EMF) on living organisms have been conducted since the middle of the last century. Thus, it has been established that EMFs can affect biochemical reactions and the behaviour of charged molecules near membranes (Barnes, 1992), namely: create electric fields in conductors, exert a force on moving charge carriers, change the diffusion rate through membranes, distort bond angles, which affects the binding of proteins and the synthesis of macromolecules, etc.

Research in the field of molecular biology has made it possible to establish the presence of endogenous bioelectric signals, as well as to determine their sources and influence on embryogenesis, regeneration and neoplasms. Ionic fluxes and voltage gradients generated by ion channels and pumps are key regulators of cell proliferation, migration, and differentiation (Levin, 2003). Closed channels have movable folds in proteins that can alternately be open, allowing ions to pass through the channel, or closed, preventing ions from passing through the channel (Sherwood et al., 2005).

The uneven distribution of several key ions (Na+, Cl-, K+) between the intracellular and extracellular fluids and their selective movement across the plasma membrane determines the electrical properties of the membrane (Panagopoulos et al., 2002; Pall, 2013). All plasma membranes have a membrane potential; therefore, the membrane potential (Vmem) leads to charge separation across the membrane (Sherwood et al., 2005). Every time the Vmem value differs from 0 mV, in the positive or negative direction, the membrane is in a state of polarization. The magnitude of the polarization potential is directly proportional to the number of positive and negative charges separated by the membrane. In other words, changes in Vmem cause changes in the movement of ions across the membrane. Trigger events, such as exposure to an exogenous electromagnetic field (EMF), whose frequencies resonate with endogenous EMF, also cause changes in membrane permeability (Funk et al., 2009). Changes in membrane potential, among other things, regulate the proliferation of progenitor cells, stem cells and regenerative systems (Sarah Sundelacruz et al., 2009), as well as the efficiency of cytotoxic T lymphocytes (Jesse A et.al, 2019).

Other studies have shown that voltage gradients were not just membrane potentials, but specific signals for key metabolic processes in regenerative wound healing (Hotary and Robinson, 1992; Levin, 2007; Nuccitelli, 2003). These signals determine the migration path of cells, forming voltage gradients between the intracellular and extracellular environment (Funk and Monsees, 2006). Voltage gradients are localized DC electric fields that turn on and off at different stages of development (McGaig et al., 2005). They spread into the extracellular space, as well as into the cytoplasm of one or more cells connected by gap junctions (Funk et al., 2009). These gradients can penetrate the cell membrane, into the cytoplasm, and even the membrane of the cell nucleus through signal transmission, while the EMF signal is received through receptors on the cell surface, and then processed by G-proteins that bind the receptors to effectors such as ion channels (Ermakov et al. others, 2012). It is known that these signalling processes have a correlation between the presence of EMF gradients and the cellular response (Funk and Monsees, 2006; Sundelacruz et al., 2013).

In the process of technical implementation of the BIOL device, these particular features were taken into account and the frequencies of the meter and decimeter wave ranges were selected. Back in 1993 (Adey et al.) It was found that a sinusoidal waveform, which creates coherent fields, has a stimulating effect on the immune system. For this, repetitive signals must be generated regularly and must be present for a certain minimum period of time (Litovitz et al., 1993). This resonant coherence is the key to producing larger effects with low thresholds (Panagopoulos et al., 2002). Our studies have shown that a triangular waveform is more efficient than a sinusoidal one due to the uniform distribution of the carrier frequency over the spectrum. Therefore, it is this waveform that is used in BIOL. Depending on the EMF parameters (“what field we are treating”) and the target biological process (“what we are treating”), either stimulation/activation of biochemical processes or inhibition/suppression can occur. And given the effect of EMF on biochemical reactions and the behaviour of charged molecules near cell membranes, the increase in the effectiveness of the drugs used in combination with the treatment with the BIOL apparatus becomes explainable (noted in practice). By changing the permeability of the cell membrane using EMF, we increase the possibility of the formation of an immunological synapse between an infected or oncological cell and cytotoxic T-lymphocytes, which allows the latter to efficiently release perforins1 and granzymes2 into the affected cells. Perforin molecules are incorporated into cell membranes and form pores through which granzymes enter the cell, stimulating the death of affected cells (along the path of regulated apoptosis - the process of programmed cell death). Initially, the biological activity of the radiation of the medical device BIOL was tested at the Department of Genetics and Cytology of the Kharkiv National University. V.N. Karazin on the cytobiophysical method (2008). The effect of EMF on buccal epithelial cells in vitro was studied at different exposure times on donors. The normalizing effect on the bioenergetic properties of the cell nuclei of native human epithelial cells was reliably established, which made it possible to draw conclusions about the healing effect of EMF radiation.

The BIOL device was clinically tested at the Kyiv Regional Hospital No. 2 (2009) for patients aged 17-94 with the following diseases: intercostal neuralgia, osteochondrosis, rhinolaryngitis, rhinosinusitis, osteoarthritis, rhinitis. The results showed an improvement in physical condition in 80% of patients (a 40% decrease in pain syndrome and a 20% decrease in clinical manifestations of upper respiratory tract diseases) and in 20% no changes in the course of the disease were observed.

In 2009, for 128 patients of the sanatorium "Ukraine" (Simferopol, Crimea), the BIOL device was used as part of the complex therapy of hypertension of the II-III degree (of which, with a concomitant diagnosis of chronic ischemic heart disease (CHD), angina pectoris - 125, conditions after arriving cerebral circulation disorders - 3). A reliable therapeutic effect was obtained, confirmed by hemodynamic parameters and laboratory studies. More than 50% of patients noted a significant improvement in well-being, a decrease in the number of angina attacks and an increase in the action of nitrates (cardiket, nitroglycerin, isoket).

In 2011, in several research centres in Europe, the BIOL device was used for patients with the following diseases (21): prostate adenoma, breast cancer (with and without metastases), lung and colon tumours (adenocarcinoma), and squamous cell carcinoma of the larynx. All patients noted an improvement in the quality of life and a significant reduction in pain. In 4 patients, the state of the tumour remained unchanged (did not improve but did not worsen). The remaining 17 patients showed a decrease in tumours by an average of 15% (10-18%), and in patients with metastases, a decrease in the degree of metastasis (in one of the patients, metastases disappeared).

In 2017-2018, BIOL was used in Taiwan for 3 patients with nasopharyngeal carcinoma, ankylosing spondylitis and colorectal cancer. After a year, all patients showed regression of the disease (according to CT data) and an improvement in the quality of life.

Note 1: Activated killer T cells kill cells with a foreign antigen, to which they have a receptor, by inserting perforins (proteins that form a wide, non-closing opening in the membrane) into their membranes and injecting toxins (granzymes) inside.

Note 2: Granzymes are serine proteases released by cytoplasmic granules of cytotoxic T cells and natural killer (NK) cells. They induce programmed cell death (apoptosis) in the target cell, thereby eliminating cells that have become cancerous or infected with viruses or bacteria. Granzymes also kill bacteria and inhibit viral replication. In NK cells and T cells, granzymes are packed in cytotoxic granules with perforin.